Insider Purchases: Inside the Buy
Tag: Wall Street
🥚 Vital Farms (VITL): The Great Egg Glut of 2026
Vital Farms stock has been absolutely scrambled by the 2026 egg glut, plunging more than 80% from its highs as profitability collapsed and short sellers flooded the farm. But coordinated insider buying, a debt-free balance sheet, and extreme institutional ownership suggest the setup may be far more explosive than the market currently realizes.
CHRW 2026: The “Karaoke Crash” and the Many Insiders “Buy-The-Dips”
A tiny “AI logistics” headline sparked a selloff in C.H. Robinson (CHRW). Insiders responded by buying. Is this a fear-driven dip or a signal that Lean AI is turning logistics into a margin machine?
Progress Software CEO Buys In — Maybe It’s More Than Just... Progress?
Progress Software's CEO and a director are buying shares, signaling confidence as the company posts strong earnings and raises guidance. With institutional investors owning over 121% of the float, is this under-the-radar compounder set for a rerating?
Moderna: Messenger RNA Medicines Powerhouse Sends A New Message — “Discount!”
Insiders dropped $6M on Moderna stock. With a massive mRNA pipeline and deep-pocketed backers, is this biotech beast ready to roar again?
💼 The Godman Sachs Group, Inc. (GS): Where Wall Street Power Lunches with Olympus 🍽️📈
With soaring Q1 profits, billions returned to shareholders, and insiders buying in, Goldman Sachs is flexing its Wall Street muscle. From record M&A rankings to a $40B buyback plan, find out why GS might be the most solid financial play in your portfolio (and possibly Olympus). ⚖️💰